Medical/Pharmaceuticals

Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week

* Establishing actionable frameworks to advance precision medicine and longevity science * The declaration highlights the impact longevity and precision medicine can have on supporting healthy communities, and engages leaders to work towards actionable solutions, drive consensus among global ...

2025-04-19 01:12 4889

VISTA Eye Specialist and Tzu Chi Malaysia Continue Their Mission to Restore Sight for Underprivileged

PETALING JAYA, Malaysia, April 18, 2025 /PRNewswire/ -- In a heartfelt continuation of their mission to serve the underserved,VISTA Eye Specialist (VISTA) andTzu Chi Malaysia (Tzu Chi) have once again partnered to restore sight for the underprivileged through their second100 Cataract Surgery Prog...

2025-04-18 08:00 4157

ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone

Showcasing at ASCRS 2025: * More than 2 million cases planned with ZEISS VERACITY Surgery Planner: Growing use of one of the leading digital planning solutions for cataract surgery in the U.S. is a testament to the increased adoption of the ZEISS Cataract Workflow digital solutions by surgeons...

2025-04-17 21:00 3204

Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights

SHANGHAI, April 17, 2025 /PRNewswire/ -- Henlius (2696.HK) held its 2025 Global R&D Day themed "Collaborate to Create," gathering senior executives, experts, and industry leaders to discuss R&D advances, strategic planning, and cutting-edge therapies. The event attracted hundreds from academia, i...

2025-04-17 16:07 6143

World Hemophilia Day 2025 - April 17, 2025 - "Access for all: Women and girls bleed too"

MONTREAL, April 17, 2025 /PRNewswire/ -- On April 17, 2025, the global bleeding disorders community will come together under the theme "Access for all: Women and girls bleed too" and celebrate World Hemophilia Day. Today, women and girls with bleeding disorders (WGBDs) are still underdiagnosed an...

2025-04-17 13:00 2681

Brain Navi Begins IPO Counseling with First Securities Inc., Setting the Stage for Global MedTech Expansion

ZHUBEI, April 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology Co., Ltd. (" Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward accessing the capital markets and advancing its long-term growth in the surgical robot technology industry.

2025-04-17 12:10 4510

Duke-NUS and T Cells Diagnostics team up to simplify T-cell analysis

* Virus-specific T-cell measurement is made easier to enable better understanding of immune responses in patients and management of human infectious diseases. SINGAPORE, April 17, 2025 /PRNewswire/ -- T Cell Diagnostics Pte. Ltd. ("TCD") has licensed an intellectual property (IP) and its relat...

2025-04-17 11:05 4196

Herbalgy Unveils Touch Cool Campaign at MTR* advertising: An Immersive Installation Fusing Pain Relief with Sustainability and Innovative Design

Download high-resolution images:    https://cutt.ly/srswmUXq HONG KONG, April 17, 2025 /PRNewswire/ -- Herbalgy Pharmaceutical Ltd. is pleased to unveil its latest public engagement initiative at MTR* advertising, the leading outdoor media plat...

2025-04-17 10:00 3596

Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]

* IFINWIL®: now TGA registered in Australia * Children diagnosed with neuroblastoma are on average just 2 years old2 * The average survival rate of children with HRNB is only 50%2 UXBRIDGE, England, April 17, 2025 /PRNewswire/ -- Norgine is pleased to announce that the Australian Therapeutic...

2025-04-17 08:01 2708

Norgine strengthens rare disease portfolio with acquisition of Theravia

Acquisition of Theravia from Mérieux Equity Partners represents meaningful step forward in Norgine's strategy for sustainable growth, adding a complementary portfolio of rare disease medicines Transaction further establishes Norgine's position as a partner of choice for commercialising rare and ...

2025-04-17 08:01 2945

Saudi Arabia and France Strengthen Health Cooperation Through Strategic Agreements in Biotech and Digital Health

PARIS, April 17, 2025 /PRNewswire/ -- On the second day of an official visit to France, His Excellency Fahad Abdulrahman AlJalajel, Minister of Health of the Kingdom of Saudi Arabia, held bilateral meetings with senior French officials including Minister for Labour, Health, Solidarity and Familie...

2025-04-17 06:21 4346

Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights

SHANGHAI, April 16, 2025 /PRNewswire/ -- Henlius (2696.HK) held its 2025 Global R&D Day under the theme of "Collaborate to Create". Senior executives from Henlius gathered with leading experts, scholars, and heads of innovation from across the industry to engage in in-depth discussions on the lat...

2025-04-16 23:30 4190

Transforming Lives with TAVI: A Milestone in Aortic Stenosis Treatment

MANILA, Philippines, April 16, 2025 /PRNewswire/ -- The Philippine Heart Center has reached a significant milestone by successfully performing six Transcatheter Aortic Valve Implantation (TAVI) procedures in a single day. This groundbreaking technique offers a minimally invasive alternative to op...

2025-04-16 20:32 3358

Global Health Innovators recognised with Abu Dhabi Global Health Week Innovation Awards for transformative impact

* Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug delivery, and novel pain treatments * Recipients include the Children's Hospital of Philadelphia, University of Pennsylvania, King Faisal Specialist Hospital & Research...

2025-04-16 20:15 3136

Fullerton Health Indonesia Launches First Executive Health Screening Centre Offering Exclusive, Private and Customised Screening in Jakarta

JAKARTA, Indonesia, April 16, 2025 /PRNewswire/ -- Fullerton Health Indonesia today officially launched its first Executive Health Screening Centre (EHS) in Jakarta, the fifth such centre in the Fullerton Health Group's executive health screening portfolio acrossAsia. The 700-square metre centre o...

2025-04-16 14:00 3825

The Lancet Child & Adolescent Health Publishes Phase III Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months

SHANGHAI, April 16, 2025 /PRNewswire/ -- The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results ofziresovir, a novel RSV-targeted antiviral drug developed by Shanghai Ark Biopharmaceutical Ltd....

2025-04-16 09:00 4576

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131 I-iodofalan[1]) in recurrent high-grade glioma (brain cancer), substan...

2025-04-16 06:45 3078

Vantage Foundation Visits SOS Children's Villages Portugal: Addressing Neglect and Breaking the Cycle

LISBON, Portugal, April 15, 2025 /PRNewswire/ -- Neglect is one of the most pervasive yet overlooked threats to a child's well-being. Unlike abandonment, neglect often goes unnoticed—leaving children trapped in cycles of chronic emotional harm, broken trust, and long-term developmental struggles....

2025-04-15 17:05 4708

Open nominations for the BIAL Award in Biomedicine 2025 with an increased amount to €350,000

Created to distinguish the most remarkable scientific discoveries in the biomedical field, this international award has been granted a growing reputation as a prelude to the Nobel Prize since it has distinguished in a former edition two authors subsequently honoured with the Nobel Prize in Medic...

2025-04-15 15:00 3425

Wang Qunbin: Leveraging Innovation and Global Operational Strengths to Contribute "Fosun Power" to the Development of Hainan Free Trade Port

HONG KONG and SHANGHAI, April 15, 2025 /PRNewswire/ -- On April 14, the 2025 Hainan Free Trade Port Global Investment Promotion Conference was held inHaikou . Jointly hosted by the People's Government ofHainan Province and the Ministry of Commerce, the conference is one of the key events in the 20...

2025-04-15 12:05 4064
1 ... 105106107108109110111 ... 381